Pure Global

HepaSphere embolization microspheres with or without delivery of doxorubicin - ARCSA Registration 23b46b18a76382bdb260ac400cd6ac31

Access comprehensive regulatory information for HepaSphere embolization microspheres with or without delivery of doxorubicin in the Ecuador medical device market through Pure Global AI's free database. This IV medical device is registered under ARCSA ID 23b46b18a76382bdb260ac400cd6ac31 and manufactured by BIOSPHERE MEDICAL S.A. The device was registered on January 02, 2020.

This page provides complete registration details including product type (Invasive), manufacturer information, authorized representative details, and regulatory compliance data from the official Ecuador ARCSA medical device database. Pure Global AI offers free access to Ecuador's complete medical device registry.

Free Database
Powered by Pure Global AI
ARCSA Official Data
IV
23b46b18a76382bdb260ac400cd6ac31
HepaSphere embolization microspheres with or without delivery of doxorubicin
ARCSA ID: 23b46b18a76382bdb260ac400cd6ac31
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Device Classification
Risk Class
IV
Product Type
Invasive
Brand Name
MERIT MEDICAL
Commercial Name
Embolization Microspheres
Registration Information
Analysis ID
23b46b18a76382bdb260ac400cd6ac31
Registration Date
January 02, 2020
Expiration Date
January 02, 2025
Product Use

HEPASPHERE™ MICROSPHERES ARE INDICATED FOR USE IN EMBOLISATION OF BLOOD VESSELS WITH OR WITHOUT DELIVERY OF DOXORUBICIN HCI FOR THERAPEUTIC OR PREOPERATIVE PURPOSES IN THE FOLLOWING PROCEDURES: • EMBOLISATION OF HEPATOCELLULAR CARCINOMA • EMBOLISATION OF METASTASES TO THE LIVER

Manufacturer
City
ROISSY IN FRANCE
Country
FRENCH
Address
PARC DES NATIONS PARIS NORD 2, 383 RUE DE LA BELLE ETOILE, 95700
Product Owner
Name
MERIT MEDICAL SYSTEMS INC
Country
UNITED STATES
Authorized Representative
Address
CALLE BY. LEOPOLDO BENTEZ. INTERSECCIN: OF. JOAQUN ORRANTIA.
Phone
42109097